课题基金 / 基金详情

Characterization of the Wilms tumor suppressor gene X (WTX) in tumorigenesis and normal kidney development of the mouse

Characterization of the Wilms tumor suppressor gene X (WTX) in tumorigenesis and normal kidney development of the mouse
Wilms 肿瘤抑制基因 X (WTX) 在小鼠肿瘤发生和正常肾脏发育中的表征
批准号:
84743245
负责人:
Dr. Alexa Burger
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2008
资助国家:
德国
项目状态:
已结题
起止时间:
2007-12-31 至 2009-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
肾母细胞瘤是最常见的儿童肾癌,与肾脏器官发生密切相关。在Wilms肿瘤中发现与肾脏发育相关的各种基因不适当地失活,例如WT1,而其他基因似乎被激活,例如编码Wnt信号通路成分的CTNNB1;然而,对于大多数Wilms肿瘤,没有一致的特异性异常被检测到。最近,通过在30%的Wilms肿瘤中发现一种新的失活基因,可以克服这一障碍,该基因位于X染色体上,命名为WTX。本项目的目的是研究小鼠中失活的WTX,以确定和表征其在肾发生过程中的影响。为此,我将使用有条件的WTX敲除小鼠,它允许WTX的时间和组织特异性表达,也允许我建立基于WTX功能丧失的体内Wilms肿瘤模型。我将使用这个遗传工具来显示WTX在小儿癌症以及正常肾形成中的重要相关性。综上所述,对WTX的分析将有助于得出其生物学功能、涉及的分子机制和途径,以及它在肾前体细胞致瘤事件中的作用。
英文摘要
Wilms tumor is the most common pediatric kidney cancer and closely associated with renal organogenesis. Various genes associated with kidney development are found inappropriately inactivated in Wilms tumor, e.g. WT1, while others appear activated, such as CTNNB1, encoding a component of the Wnt signaling pathway; however, for the majority of Wilms tumor, no consistently specific aberrations have been detected. Recently, this obstacle could be overcome through the discovery of a novel inactivated gene in 30% of Wilms tumor, which is located on the X chromosome and named WTX. The aim of this project is to study inactivated WTX in the mouse to identify and characterize its influence during nephrogenesis. For this purpose, I will use a conditional WTX knockout mouse, which allows temporal and tissue-specific expression of WTX, and also will allow me to establish an in vivo Wilms tumor model based on WTX loss-of-function. I will use this genetic tool to show the significant relevance of WTX in this pediatric cancer as well as in normal nephrogenesis. In summary, the analysis of WTX will allow conclusions about its biological function, involved molecular mechanisms and pathways, as well as its contribution to tumorigenic events in renal precursor cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
引起Wilms肿瘤的miRNA加工复合体突变的分子机制
  • 批准号:
    32371355
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    Tuan Anh Nguyen
  • 依托单位:
Six1在Wilms肿瘤发病中的作用及分子机制: 巴马小型猪模型的构建
  • 批准号:
    31971379
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2019
  • 负责人:
    李荣凤
  • 依托单位:
WT1在DNA损伤应答中的功能及诱导Wilms肿瘤的分子机制
  • 批准号:
    81874160
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    俞晓春
  • 依托单位:
p53基因突变促进Wilms 肿瘤发展转移的小鼠动物模型研究
  • 批准号:
    81472715
  • 项目类别:
    面上项目
  • 资助金额:
    75.0万元
  • 批准年份:
    2014
  • 负责人:
    胡强华
  • 依托单位: